ICD-10 Code M35.1: Other overlap syndromes

Key Takeaways

ICD-10 Code M35.1 (other overlap syndromes) is a billable ICD-10-CM diagnosis code valid for FY2026, effective October 1, 2025.

MCTD (also called Sharp syndrome) is the only official Applicable To inclusion term for M35.1; SLE, systemic sclerosis, and inflammatory myopathy overlaps are common clinical scenarios but are not separately listed.

M35.1 carries one Excludes1 note (M30.8) and the parent M35 category carries another (L87.1); M35.1 has no official Code Also instruction, though secondary manifestation codes are still best practice on complex claims.

Practice management software like Pabau connects ICD-10 diagnosis codes directly to billing workflows, reducing manual re-entry errors on complex rheumatology claims.

ICD-10 Code M35.1: Definition and clinical description

ICD-10 Code M35.1 is a billable ICD-10-CM diagnosis code for other overlap syndromes, connective tissue disease presentations that span two or more autoimmune diseases at once without meeting the full diagnostic criteria for any single one.

ICD-10 Code M35.1 is a billable ICD-10-CM diagnosis code under the official description “Other overlap syndromes.” It sits within the M35 block (Other systemic involvement of connective tissue), which is part of Chapter 13 of the ICD-10-CM tabular list: Diseases of the musculoskeletal system and connective tissue (M00-M99). The code is valid for FY2026, effective October 1, 2025, according to the CMS ICD-10-CM annual update.

Coders confuse M35.1 with the disease-specific codes in M32.x, M33.x, and M34.x more often than any other pattern in this block. The distinction comes down to whether the physician has documented a single primary connective tissue disease or a genuine multi-disease overlap.

M35.1 code details at a glance

The table below provides a quick-reference summary of ICD-10 Code M35.1 for coders and clinical documentation staff.

Applicable to: Conditions included under M35.1 other overlap syndromes

The “Applicable to” notes in ICD-10-CM are official inclusion terms, not guidelines. Per the CDC/NCHS ICD-10-CM official code tool and the official FY2026 tabular list, M35.1 carries exactly one Applicable To inclusion term:

• Mixed connective tissue disease (MCTD) – the sole official Applicable To inclusion term for M35.1, and the most commonly coded condition under this code; features elements of SLE, systemic sclerosis, myositis, and polymyositis with high-titer anti-U1 RNP antibodies. MCTD is also known by the historical synonym “Sharp syndrome,” named for Gordon Sharp, who first described the condition – it is not a separate Applicable To entry, just an earlier name for the same diagnosis

Three other overlap presentations are commonly coded to M35.1 in practice, even though none of them appear as separate Applicable To entries in the tabular list:

• SLE overlap with other connective tissue diseases – systemic lupus erythematosus presenting alongside features of a second CTD, where a single SLE code (M32.x) does not capture the full clinical picture
• Systemic sclerosis overlap – cases where scleroderma features occur alongside another CTD; primary systemic sclerosis sits in M34.x, but overlap presentations are commonly coded here
• Inflammatory myopathy overlap – polymyositis or dermatomyositis occurring together with another systemic CTD

The term “other overlap syndromes” in the code title is an NEC designation. It applies when a patient has documented overlap between two or more CTDs and no more specific code in ICD-10-CM captures the combination.

Mixed connective tissue disease (MCTD) and ICD-10 Code M35.1

MCTD is the primary reason coders encounter ICD-10 Code M35.1 in rheumatology practice. Understanding the documentation requirements for MCTD directly determines whether M35.1 can be assigned or whether a more specific code applies.

Clinically, MCTD is characterized by overlapping features of SLE, systemic sclerosis, and inflammatory myopathy with high-titer anti-U1 ribonucleoprotein (RNP) antibodies. The diagnostic criteria most used in practice include the Sharp criteria and the Kasukawa criteria. For ICD-10 coding, the coder does not apply diagnostic criteria directly; the physician’s documented diagnosis of MCTD or overlap syndrome triggers the code assignment.

Documentation must specify the type of overlap or the MCTD diagnosis. A note reading “connective tissue disease” alone does not support M35.1 – it would default to M35.9 (unspecified systemic involvement of connective tissue). A note reading “mixed connective tissue disease” or “overlap syndrome with SLE and systemic sclerosis features” supports M35.1 assignment.

Excludes notes and Code Also instructions for M35.1

Excludes and Code Also notes are the structural rules that govern how M35.1 interacts with other codes, and misreading them is one of the most common denial triggers for this code. In the official FY2026 tabular list, M35.1 carries a single Excludes1 note for polyangiitis overlap syndrome, which is coded to M30.8. The parent M35 category carries its own Excludes1 note for reactive perforating collagenosis, coded to L87.1, which applies across every M35.x code. M35.1 has no Excludes2 note. The AAPC ICD-10-CM code lookup presents these instructional notes alongside the code definition.

Excludes1 vs. Excludes2: The key difference

An Excludes1 note means the two conditions cannot be coded together on the same claim. Because M35.1 excludes M30.8 under Excludes1, a claim reporting M35.1 cannot also report M30.8 for the same encounter – pick whichever code matches the documented diagnosis. The M35 category’s Excludes1 note for L87.1 works the same way and applies to M35.1 along with every other code in the M35 block.

An Excludes2 note means the excluded condition is not included in the code you are using but can be reported alongside it if the patient genuinely has both conditions and both are documented. M35.1 does not carry an Excludes2 note, so there is no such exception to weigh for this code. Verify the current notes against the official FY2026 CMS tabular list before submission, since they can change with each annual update.

Code Also notes

M35.1 does not carry an official Code Also instruction in the current ICD-10-CM tabular list. That said, coding the manifestation of an overlap syndrome as a secondary code is standard practice for complex rheumatology claims, official instruction or not – for example, interstitial lung disease secondary to the underlying CTD overlap gets its own organ-system manifestation code alongside M35.1.

Skipping that secondary code on a complex rheumatology claim can still trigger a request for records or a downcoding, even without a formal Code Also note attached to M35.1. Review the full FY2026 instructional notes on the CDC/NCHS ICD-10-CM files page before finalizing claims that involve M35.1 with documented complications.

Related and adjacent ICD-10 codes to M35.1

The M35 block contains several codes that coders frequently encounter alongside or instead of M35.1, and the neighboring M36 block adds another layer: M36.8 covers connective tissue disorders that are secondary to a disease classified elsewhere, rather than a primary overlap.

M35.1 vs. similar overlap syndrome ICD-10 codes: How to choose

The single most common coding question for this block: when does M35.1 apply versus the disease-specific codes in M32.x, M33.x, or M34.x? The answer comes down to whether the physician has documented a single primary CTD diagnosis or a true multi-disease overlap.

• Use M35.1 when the physician documents “overlap syndrome,” “MCTD,” “Sharp syndrome,” or explicitly names two or more coexisting CTDs that together constitute the diagnosis
• Use M32.x when SLE is the sole or primary diagnosis, even if mild features of another CTD are incidentally noted
• Use M34.x when systemic sclerosis is the primary documented diagnosis without a concurrent separate CTD diagnosis
• Use M35.9 only as a last resort when the physician has documented “connective tissue disease” or “CTD” without any specificity about which disease or overlap type
• Do not default to M35.1 for undifferentiated connective tissue disease (UCTD) – UCTD is a distinct clinical entity where the patient has CTD features but has not evolved into a defined CTD; it may code differently depending on current AHA Coding Clinic guidance

This distinction matters for payer review. A claim submitted with M35.1 that the medical record actually supports as isolated SLE (M32.x) may trigger a medical necessity audit. The code must match the documented diagnosis, not the coder’s interpretation of the clinical features.

Single, well-defined rheumatic diagnoses fall outside this comparison entirely. Documented ankylosing spondylitis, for instance, codes to M45.5, not to anything in the M32-M35 overlap range.

Struggling to keep ICD-10 coding aligned with clinical documentation?

Pabau connects diagnosis codes directly to patient records and billing workflows, so your rheumatology team codes accurately from the first consultation note.

Book a demo

Documentation requirements for ICD-10 Code M35.1

M35.1 requires physician-level documentation specificity. A coder cannot assign this code based on lab findings or imaging alone. The following elements should be present in the medical record to support M35.1 assignment.

• Physician’s documented diagnosis of overlap syndrome, MCTD, or Sharp syndrome using those exact terms, or an explicit statement that the patient has features of two or more named CTDs simultaneously
• Clinical features from multiple CTDs documented in the notes, such as Raynaud’s phenomenon, inflammatory myopathy, synovitis, and esophageal dysmotility in the context of an MCTD diagnosis
• Serological context where available, particularly high-titer anti-U1 RNP antibody documentation for MCTD – while ICD-10-CM does not require a positive serology result to assign the code, its presence supports medical necessity if the claim is reviewed
• No superior code available – the coder should confirm that the overlap presentation cannot be captured by a more specific single-disease code in M32.x, M33.x, or M34.x

Using structured medical forms and clinical documentation templates in your practice management system helps ensure rheumatology notes capture the specificity required for complex codes like M35.1. Consistent documentation also supports patient data security and audit readiness.

Billing considerations for overlap syndrome claims

M35.1 is a billable code accepted by Medicare, Medicaid, and most commercial payers. However, prior authorization requirements vary by payer for rheumatology services. Before submitting claims, verify whether the associated procedure codes (such as evaluation and management codes or infusion codes for biologic therapy) require prior authorization when linked to M35.1 as the primary diagnosis.

Rheumatology practices using claims management software can configure coding rules to flag M35.1 claims that are missing required Code Also codes before submission, reducing first-pass denial rates on this complex code set.

Common coding errors to avoid with ICD-10 Code M35.1

These are the five errors most likely to result in denials or compliance issues when coding M35.1 in practice.

• Using M35.9 when M35.1 is supported. M35.9 (unspecified) is frequently assigned when the notes clearly document MCTD or a named overlap syndrome. If the physician has used a specific term in any of the Applicable To inclusions, M35.1 is always the more accurate choice. Payers may flag repeated M35.9 usage for audit if M35.1 is clinically appropriate. The same specificity standard applies throughout Chapter 13: M53.9 for back pain, for instance, should only be used when documentation offers no more specific dorsopathy diagnosis.
• Skipping secondary manifestation codes. M35.1 does not carry a formal Code Also instruction, but if a patient has a documented organ manifestation secondary to the overlap syndrome (interstitial lung disease, pulmonary hypertension, renal involvement), omitting that manifestation code still makes for an incomplete claim.
• Confusing Excludes1 with Excludes2. Excludes1 = never code together; Excludes2 = may code together if both conditions are documented and clinically distinct. Treating an Excludes2 note as a hard prohibition leaves legitimate secondary codes off the claim.
• Coding UCTD as M35.1. Undifferentiated connective tissue disease has features of a CTD but has not evolved into a defined overlap or single-disease CTD. It does not automatically map to M35.1. Check current AHA Coding Clinic guidance for the appropriate code assignment for UCTD.
• Assigning M35.1 without physician documentation of overlap. ICD-10 Code M35.1 is a diagnosis code assigned based on the physician’s documented diagnosis, not on the coder’s clinical interpretation. If the record shows only individual CTD features without an explicit overlap diagnosis, the coder should query the physician rather than assign M35.1 independently.

How practice management software supports M35.1 coding

Rheumatology and autoimmune practices managing complex codes like M35.1, along with osteopathic practices managing overlapping musculoskeletal and connective tissue findings, run into the same documentation-to-billing mismatch that manual workflows make worse. When a clinician documents an MCTD overlap in their consultation notes but billing staff then re-enter the diagnosis into a separate coding tool, transcription errors and missed manifestation codes are almost inevitable.

Pabau integrates ICD-10 code lookup directly within the clinical record, allowing clinicians to select diagnosis codes like M35.1 at the point of documentation without switching between tools. This single-source approach means the code that appears on the claim matches the physician’s documented diagnosis in the patient record.

For practices managing multiple locations or high volumes of rheumatology consultations, Pabau’s clinical records functionality supports structured note templates that can be configured for autoimmune and connective tissue disease consultations. This helps ensure the documentation specificity needed to support M35.1 is captured consistently across the team.

Practices looking for broader operational support can explore how healthcare CRM software integrates patient data across the care journey, or how physical therapy practices handle similarly detailed musculoskeletal documentation.

For practices already managing rheumatology billing, the role of practice management software in reducing coding errors is well established across autoimmune specialty clinics.

Conclusion

ICD-10 Code M35.1 is the correct code for other overlap syndromes including mixed connective tissue disease and Sharp syndrome, and it requires specific physician documentation to use accurately. The most common failure points are defaulting to M35.9 when M35.1 is supported, missing Code Also requirements, and misapplying the code to undifferentiated CTD presentations.

Pabau’s integrated clinical records and claims management tools help rheumatology practices keep documentation and billing aligned, so complex codes like M35.1 stay accurate from the consultation note to the submitted claim. Book a demo to see how Pabau supports rheumatology and autoimmune specialty coding workflows.

Continue your research

Need a structured approach to rheumatology documentation? Pabau’s digital forms let you build consultation templates that capture the documentation specificity ICD-10 complex codes require.

Managing claims accuracy across a multi-clinician rheumatology team? Compliance management software from Pabau helps practices build audit-ready documentation workflows.

Coding musculoskeletal conditions elsewhere in Chapter 13? M92.9 follows the same specificity standard for juvenile osteochondrosis diagnoses.

Frequently Asked Questions